- Home
- RDZN vs HOWL Comparison
RDZN vs HOWL Comparison
Compare RDZN & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDZN
- HOWL
- Stock Information
- Founded
- RDZN 2015
- HOWL 2017
- Country
- RDZN United States
- HOWL United States
- Employees
- RDZN N/A
- HOWL N/A
- Industry
- RDZN Blank Checks
- HOWL Biotechnology: Pharmaceutical Preparations
- Sector
- RDZN Finance
- HOWL Health Care
- Exchange
- RDZN Nasdaq
- HOWL Nasdaq
- Market Cap
- RDZN 75.2M
- HOWL 64.5M
- IPO Year
- RDZN N/A
- HOWL 2021
- Fundamental
- Price
- RDZN $1.39
- HOWL $1.65
- Analyst Decision
- RDZN Strong Buy
- HOWL Strong Buy
- Analyst Count
- RDZN 2
- HOWL 5
- Target Price
- RDZN $5.00
- HOWL $7.20
- AVG Volume (30 Days)
- RDZN 584.0K
- HOWL 1.3M
- Earning Date
- RDZN 11-12-2025
- HOWL 11-14-2025
- Dividend Yield
- RDZN N/A
- HOWL N/A
- EPS Growth
- RDZN N/A
- HOWL N/A
- EPS
- RDZN N/A
- HOWL N/A
- Revenue
- RDZN $46,230,126.00
- HOWL N/A
- Revenue This Year
- RDZN $38.45
- HOWL N/A
- Revenue Next Year
- RDZN $66.38
- HOWL N/A
- P/E Ratio
- RDZN N/A
- HOWL N/A
- Revenue Growth
- RDZN N/A
- HOWL N/A
- 52 Week Low
- RDZN $0.68
- HOWL $0.60
- 52 Week High
- RDZN $2.99
- HOWL $3.12
- Technical
- Relative Strength Index (RSI)
- RDZN 60.21
- HOWL 50.22
- Support Level
- RDZN $1.15
- HOWL $1.55
- Resistance Level
- RDZN $1.42
- HOWL $1.83
- Average True Range (ATR)
- RDZN 0.13
- HOWL 0.13
- MACD
- RDZN 0.01
- HOWL -0.02
- Stochastic Oscillator
- RDZN 70.72
- HOWL 30.70
About RDZN Roadzen Inc.
Roadzen Inc is an insurance technology company on a mission to transform auto insurance powered by AI. Its clients comprise insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express.
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.